Related Experiment Video
Updated: Jul 11, 2025
07:51
Refined Murine Model of Idiopathic Pulmonary Fibrosis
Published on: June 17, 2025
114
Pulmonary fibroelastosis - A review
Dan J K Yombo1, Satish K Madala2, Chanukya P Vemulapalli2
1Division of Pulmonary Medicine, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine Cincinnati, OH, USA.
Summary
Excessive elastin deposition in the lung impairs function and survival, especially in interstitial lung diseases. Current therapies do not effectively reduce this elastin burden, necessitating new treatment strategies.
Area of Science:
- Pulmonary Medicine
- Biochemistry
- Extracellular Matrix Biology
Background:
- Elastin is a key lung extracellular matrix protein providing elasticity essential for gas exchange.
- Excessive elastin deposition (elastosis) impairs lung compliance, ventilation, and gas exchange.
- Elastosis correlates with declining lung function and survival in interstitial lung diseases.
Purpose of the Study:
- To review elastin's role in healthy lungs.
- To summarize the impact of elastosis in pulmonary diseases.
- To evaluate current understanding of elastin regulation and dysregulation to guide future therapies.
Main Methods:
- Literature review of elastin's function and role in lung disease.
- Analysis of elastin's regulatory mechanisms.
- Evaluation of therapeutic strategies for elastosis.
Main Results:
- Elastin is crucial for lung elasticity and gas exchange.
- Dysregulated elastosis significantly worsens lung disease outcomes.
- No current therapies effectively target excessive elastin accumulation in the lung.
Conclusions:
- Understanding elastin regulation is critical for developing novel therapies.
- Targeting elastin dysregulation may improve lung function and survival in pulmonary diseases.
- Further research is needed to develop effective treatments for lung elastosis.
Related Concept Videos
01:25Pulmonary Function Tests
345
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
345
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
01:21Acute Respiratory Failure-II
249
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
249
01:20COPD: Pathogenesis and Clinical Features
302
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
302
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K